Urinary Retention and Severe Hyponatremia: An Unusual Presentation of COVID-19
  • Ahmed Osman Saleh
    Internal Medicine Department, Medical Education, Hamad Medical Corporation, Doha, Qatar
  • Shaikha D. Al-Shokri
    Internal Medicine Department, Medical Education, Hamad Medical Corporation, Doha, Qatar
  • Ashraf Ahmed
    Internal Medicine Department, Medical Education, Hamad Medical Corporation, Doha, Qatar
  • Ahmed Elmustafa Musa
    Diagnostic and Interventional Radiology Department, Medical Education, Hamad Medical Corporation, Doha, Qatar
  • Mouhand FH Mohamed
    Internal Medicine Department, Medical Education, Hamad Medical Corporation, Doha, Qatar

Keywords

COVID-19, coronavirus, SARS-CoV-2, hyponatremia, SIADH, urine retention

Abstract

Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019. The disease is caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2). A few published cases have linked COVID-19 and hyponatremia. The mechanism of hyponatremia in these cases is related to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Here we present a unique case of urinary retention and SIADH as unusual presenting features of SARS-CoV-2 infection.

VIEW THE ENTIRE ARTICLE

References

  • World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report – 1. 21 January 2020.
  • Centers for Disease Control and Prevention. Symptoms of coronavirus. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html (accessed 19 August 2020).
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069.
  • Yousaf Z, Al-Shokri SD, Al-Soub H, Mohamed MFH. COVID-19-associated SIADH: a clue in the times of pandemic! Am J Physiol Endocrinol Metab 2020;318(6):E882–E885.
  • Habib MB, Sardar S, Sajid J. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19. IDCases 2020;21:e00859.
  • Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther 2020;26(5):499–501.
  • Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry B. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis 2020;7(2):91–96.
  • Galperin I, Friedmann R, Feldman H, Sonnenblick M. Urinary retention: a cause of hyponatremia? Gerontology 2007;53(3):121–124.
  • Schettini DA, Freitas FG, Tomotani DY, Alves JC, Bafi AT, Machado FR. Incidence and risk factors for urinary retention in critically ill patients. Nurs Crit Care 2018;24(6):355–361.
  • Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 2020;117(21):11727–11734.
  • Giuliani C, Peri A. Effects of hyponatremia on the brain. J Clin Med 2014;3(4):1163–1177.

    • Views: 1480
    HTML downloads: 957
    PDF downloads: 703

    Published: 2020-09-11
    Issue: 2020: Vol 7 No 10 (view)

    How to cite:
    1.
    Saleh AO, D. Al-Shokri S, Ahmed A, Musa AE, Mohamed MF. Urinary Retention and Severe Hyponatremia: An Unusual Presentation of COVID-19. EJCRIM 2020;7 doi:10.12890/2020_001905.